<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease - Walters, JAE - 2018 | Cochrane Library</title> <meta content="Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease - Walters, JAE - 2018 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006897.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease - Walters, JAE - 2018 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006897.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD006897.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease" name="citation_title"/> <meta content="Julia AE Walters" name="citation_author"/> <meta content="La Trobe University" name="citation_author_institution"/> <meta content="Julia.Walters@utas.edu.au" name="citation_author_email"/> <meta content="Daniel J Tan" name="citation_author"/> <meta content="University of Tasmania" name="citation_author_institution"/> <meta content="Clinton J White" name="citation_author"/> <meta content="University of Tasmania" name="citation_author_institution"/> <meta content="Richard Wood‐Baker" name="citation_author"/> <meta content="University of Tasmania" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD006897.pub4" name="citation_doi"/> <meta content="2018" name="citation_date"/> <meta content="2018/03/19" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006897.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006897.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006897.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Administration, Oral; Adrenal Cortex Hormones [*administration &amp; dosage, adverse effects]; Disease Progression; Drug Administration Schedule; Glucocorticoids [administration &amp; dosage, adverse effects]; Methylprednisolone [administration &amp; dosage, adverse effects]; Prednisolone [administration &amp; dosage, adverse effects]; Pulmonary Disease, Chronic Obstructive [*drug therapy]; Quality of Life; Randomized Controlled Trials as Topic; Treatment Failure" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD006897.pub4&amp;doi=10.1002/14651858.CD006897.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="xNbeAU8n";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006897\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006897\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ms","fr","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD006897.pub4",title:"Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease",firstPublishedDate:"Mar 19, 2018 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Airways Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006897.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006897.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD006897.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD006897.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006897.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD006897.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006897.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD006897.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD006897.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006897.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>13686 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD006897.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-sec-0087"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-sec-0034"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-sec-0035"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-sec-0058"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-sec-0081"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/appendices#CD006897-sec-0092"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/table_n/CD006897StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/table_n/CD006897StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2018 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/information#CD006897-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Julia AE Walters</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/information#CD006897-cr-0003">Daniel J Tan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/information#CD006897-cr-0004">Clinton J White</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD006897.pub4/information#CD006897-cr-0005">Richard Wood‐Baker</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/information/en#CD006897-sec-0103">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 19 March 2018 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD006897.pub4">https://doi.org/10.1002/14651858.CD006897.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD006897-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006897-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD006897-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006897-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006897-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006897-abs-0011">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD006897-abs-0001" lang="en"> <section id="CD006897-sec-0001"> <h3 class="title" id="CD006897-sec-0001">Background</h3> <p>Current guidelines recommend that patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) should be treated with systemic corticosteroid for seven to 14 days. Intermittent systemic corticosteroid use is cumulatively associated with adverse effects such as osteoporosis, hyperglycaemia and muscle weakness. Shorter treatment could reduce adverse effects. </p> </section> <section id="CD006897-sec-0002"> <h3 class="title" id="CD006897-sec-0002">Objectives</h3> <p>To compare the efficacy of short‐duration (seven or fewer days) and conventional longer‐duration (longer than seven days) systemic corticosteroid treatment of adults with acute exacerbations of COPD. </p> </section> <section id="CD006897-sec-0003"> <h3 class="title" id="CD006897-sec-0003">Search methods</h3> <p>Searches were carried out using the Cochrane Airways Group Specialised Register of Trials, MEDLINE and CENTRAL (Cochrane Central Register of Controlled Trials) and ongoing trials registers up to March 2017. </p> </section> <section id="CD006897-sec-0004"> <h3 class="title" id="CD006897-sec-0004">Selection criteria</h3> <p>Randomised controlled trials comparing different durations of systemic corticosteroid defined as short (i.e. seven or fewer days) or longer (i.e. longer than seven days). Other interventions—bronchodilators and antibiotics—were standardised. Studies with participants requiring assisted ventilation were excluded. </p> </section> <section id="CD006897-sec-0005"> <h3 class="title" id="CD006897-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures as expected by The Cochrane Collaboration.</p> </section> <section id="CD006897-sec-0006"> <h3 class="title" id="CD006897-sec-0006">Main results</h3> <p>Eight studies with 582 participants met the inclusion criteria, of which five studies conducted in hospitals with 519 participants (range 28 to 296) contributed to the meta‐analysis. Mean ages of study participants were 65 to 73 years, the proportion of male participants varied (58% to 84%) and COPD was classified as severe or very severe. Corticosteroid treatment was given at equivalent daily doses for three to seven days for short‐duration treatment and for 10 to 15 days for longer‐duration treatment. Five studies administered oral prednisolone (30 mg in four, tapered in one), and two studies provided intravenous corticosteroid treatment. Studies contributing to the meta‐analysis were at low risk of selection, performance, detection and attrition bias. In four studies we did not find a difference in risk of treatment failure between short‐duration and longer‐duration systemic corticosteroid treatment (n = 457; odds ratio (OR) 0.72, 95% confidence interval (CI) 0.36 to 1.46)), which was equivalent to 22 fewer per 1000 for short‐duration treatment (95% CI 51 fewer to 34 more). No difference in risk of relapse (a new event) was observed between short‐duration and longer‐duration systemic corticosteroid treatment (n = 457; OR 1.04, 95% CI 0.70 to 1.56), which was equivalent to nine fewer per 1000 for short‐duration treatment (95% CI 68 fewer to 100 more). Time to the next COPD exacerbation did not differ in one large study that was powered to detect non‐inferiority and compared five days versus 14 days of systemic corticosteroid treatment (n = 311; hazard ratio 0.95, 95% CI 0.66 to 1.37). In five studies no difference in the likelihood of an adverse event was found between short‐duration and longer‐duration systemic corticosteroid treatment (n = 503; OR 0.89, 95% CI 0.46 to 1.69, or nine fewer per 1000 (95% CI 44 fewer to 51 more)). Length of hospital stay (n = 421; mean difference (MD) ‐0.61 days, 95% CI ‐1.51 to 0.28) and lung function at the end of treatment (n = 185; MD FEV1 ‐0.04 L; 95% CI ‐0.19 to 0.10) did not differ between short‐duration and longer‐duration treatment. </p> </section> <section id="CD006897-sec-0007"> <h3 class="title" id="CD006897-sec-0007">Authors' conclusions</h3> <p>Information from a new large study has increased our confidence that five days of oral corticosteroids is likely to be sufficient for treatment of adults with acute exacerbations of COPD, and this review suggests that the likelihood is low that shorter courses of systemic corticosteroids (of around five days) lead to worse outcomes than are seen with longer (10 to 14 days) courses. We graded most available evidence as moderate in quality because of imprecision; further research may have an important impact on our confidence in the estimates of effect or may change the estimates. The studies in this review did not include people with mild or moderate COPD; further studies comparing short‐duration systemic corticosteroid versus conventional longer‐duration systemic corticosteroid for treatment of adults with acute exacerbations of COPD are required. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD006897-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD006897-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD006897-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD006897-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD006897-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD006897-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD006897-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD006897-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD006897-abs-0003" lang="en"> <h3>Are shorter courses of systemic steroids as effective as conventional longer courses in the treatment of patients with flare‐ups of COPD? </h3> <p><b>Why is this question important?</b> </p> <p>Chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis, is a long‐term lung condition that is commonly associated with smoking. Patients with COPD may experience flare‐ups (exacerbations), often precipitated by infection, in which symptoms such as breathlessness, cough and phlegm become markedly worse, and extra treatment or admission to hospital is required. </p> <p>Systemic (i.e. not inhaled) corticosteroids, such as prednisolone, prednisone and cortisone, are commonly used in the treatment of patients with these flare‐ups (exacerbations). We wanted to assess whether a shorter course (seven or fewer days) of this treatment was as good as a course of usual length (longer than seven days) and caused fewer side effects. </p> <p><b>How did we answer the question?</b> </p> <p>We looked for all studies that compared oral or injected corticosteroid treatment given for seven or fewer days versus treatment given for longer than seven days in people with acute exacerbations of COPD. </p> <p><b>What did we find?</b> </p> <p>We found eight studies that included 582 people with COPD who experienced a flare‐up that required extra treatment in hospital. These studies compared oral or injected corticosteroid treatment given for seven or fewer days versus treatment for longer than seven days. Most of the people in these studies were in their late sixties and had severe or very severe symptoms of COPD; more men than women took part. The last search for studies to be included in the review was conducted in March 2017. </p> <p>No differences were observed between shorter and longer courses of treatment. People treated for seven or fewer days did not have a higher rate of treatment failure or longer time to their next exacerbation; the number of people who avoided treatment failure ranged from 51 fewer to 34 more per 1000 treated (average 22 fewer people per 1000). Time in hospital and lung function (blowing tests) at the end of treatment were not different. No differences in side effects or death were noted between treatments. Information on quality of life, which is an important outcome for people with COPD, is limited, as only one study measured it. </p> <p>The eight studies included in this review were generally well designed, and the quality of the evidence was rated as moderate because of imprecision in results; more research, especially involving people with less severe COPD, is needed. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD006897-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD006897-sec-0087"></div> <h3 class="title" id="CD006897-sec-0088">Implications for practice</h3> <section id="CD006897-sec-0088"> <p>We have obtained information from one new large study that has increased our confidence that five days of oral corticosteroids is likely to be sufficient for treatment of patients with exacerbations of COPD, and this review suggests that the likelihood that shorter courses of systemic corticosteroids (of around five days) lead to worse outcomes compared with longer (10 to 14 days) courses is low. Most evidence was graded as having moderate quality as the result of imprecision; further research may have an important impact on our confidence in the estimates of effect or may change these estimates. </p> </section> <h3 class="title" id="CD006897-sec-0089">Implications for research</h3> <section id="CD006897-sec-0089"> <p>The studies in this review did not include people with mild or moderate COPD, and further studies are required to compare short‐duration systemic corticosteroid versus conventional, longer‐duration treatment for people with acute exacerbations in this group. Studies should use validated patient‐reported exacerbation outcomes (<a href="./references#CD006897-bbs2-0054" title="JonesPW , LamarcaR , ChuecosF , SinghD , AgustiA , BatemanED , et al. Characterisation and impact of reported and unreported exacerbations: results from ATTAIN. European Respiratory Journal2014;epub ahead of print:doi:10.1183/09031936.00038814. ">Jones 2014</a>; <a href="./references#CD006897-bbs2-0058" title="LeidyNK , MurrayLT , JonesP , SethiS . Performance of the EXAcerbations of Chronic Pulmonary Disease Tool Patient‐reported Outcome Measure in three clinical trials of chronic obstructive pulmonary disease. Annals of the American Thoracic Society2014;11(3):316‐25. ">Leidy 2014</a>), and this review reinforces the need for researchers to publish results of all completed clinical trials. However, difficulties are associated with recruiting participants to studies with this clinical question in many countries in which early treatment in the community is promoted. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD006897-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD006897-sec-0029"></div> <div class="table" id="CD006897-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">SCS treatment for 7 or fewer days compared with SCS treatment for longer than 7 days for acute exacerbations of COPD</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SCS treatment for 7 or fewer days compared with SCS treatment for longer than 7 days for acute exacerbations of COPD</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with acute exacerbations of COPD<br/> <b>Settings:</b> hospital‐initiated treatment<br/> <b>Intervention:</b> SCS treatment for 7 or fewer days<br/> <b>Comparison:</b> SCS treatment for longer than 7 days </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SCS treatment for longer than 7 days</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SCS treatment for 7 or fewer days</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment failure</b><br/> Need for additional treatment<br/> Follow‐up: 10 to 14 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>83 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>61 per 1000</b><br/> (32 to 117) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.72</b> <br/> (0.36 to 1.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>457<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Equivalent to 22 fewer (95% CI 51 fewer to 34 more)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relapse</b><br/> New acute exacerbation or COPD‐related admission<br/> Follow‐up: 14 to 180 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>295 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>304 per 1000</b><br/> (227 to 395) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.04</b> <br/> (0.7 to 1.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>478<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In one study (<a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>), hazard ratio for time to re‐exacerbation was 0.95 (95% CI 0.66 to 1.37) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse drug effect</b> —<b>hyperglycaemia</b><br/> Follow‐up: 3 to 14 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>442 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>439 per 1000</b><br/> (336 to 548) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.99</b> <br/> (0.64 to 1.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>345<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse drug effects</b><br/> Gastrointestinal tract bleeding, symptomatic gastrointestinal reflux, symptoms of congestive heart failure or ischaemic heart disease, sleep disturbance, fractures, depression<br/> Follow‐up: 10 to 180 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>84 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>75 per 1000</b><br/> (40 to 135) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.88</b> <br/> (0.46 to 1.7) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>503<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b><br/> Follow‐up: 14 to 180 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>71 per 1000</b><br/> (32 to 147) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.91</b> <br/> (0.4 to 2.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>336<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Length of hospitalisation</b><br/> (days)<br/> Follow‐up: 3 to 14 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean length of hospitalisation in control groups was<br/> <b>10 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean length of hospitalisation in intervention groups was<br/> <b>0.61 lower</b> (1.51 lower to 0.28 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>421<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lung function (end of treatment)</b><br/> FEV<sub>1</sub> (L)<br/> Follow‐up: 10 to 14 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean FEV<sub>1</sub> in control groups ranged from 0.84 to 1.14 L </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean lung function (end of treatment) in intervention groups was<br/> <b>0.04 lower</b> (0.19 lower to 0.10 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>187<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>a,c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Health‐related quality of life (QOL)</b> </p> <p>Overall score (includes activity limitations, symptoms, fatigue, emotional functioning); scale 0 best to 6 worst; minimum important difference 0.5 </p> <p>Follow‐up: 30 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean QOL score in control groups was 1.24</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean QOL score in intervention groups was <b>0.06 higher</b> (‐0.16 lower to 0.28 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>271 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Wide confidence intervals include significant benefit or harm (‐1 for imprecision).<br/> <sup>b</sup>Participants and physicians not blinded to treatment in one study (‐1 for risk of bias).<br/> <sup>c</sup>Participants and physicians not blinded to treatment in one study; however risk of bias for the outcome measurement is considered low.<br/> <sup>d</sup>High risk of attrition bias in one study (‐1 for risk of bias).<br/> <sup>e</sup>Significant unexplained heterogeneity (‐1 for inconsistency). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD006897-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD006897-sec-0030"></div> <section id="CD006897-sec-0031"> <h3 class="title" id="CD006897-sec-0031">Description of the condition</h3> <p>Chronic obstructive pulmonary disease (COPD) is characterised by persistent airflow limitation that is usually progressive and is associated with an enhanced chronic inflammatory response to noxious particles or gases in the airways and the lung (<a href="./references#CD006897-bbs2-0048" title="GOLD . Global Strategy for the Diagnosis, Management and Prevention of COPD, 2014. http://www.goldcopd.org/. ">GOLD 2014</a>). A diagnosis of COPD is considered on a clinical basis in the presence of symptoms such as dyspnoea, chronic cough or sputum production and exposure to known risk factors. Confirmation of COPD diagnosis is based on demonstration of persistent airflow limitation with spirometry, according to the criterion of postbronchodilator forced expiratory volume in one second (FEV<sub>1</sub>)/forced vital capacity (FVC) ratio less than 0.7, as specified in guidelines included in GOLD (Global Strategy for Diagnosis, Management, and Prevention of COPD) (<a href="./references#CD006897-bbs2-0048" title="GOLD . Global Strategy for the Diagnosis, Management and Prevention of COPD, 2014. http://www.goldcopd.org/. ">GOLD 2014</a>). However, heterogeneity (<a href="./references#CD006897-bbs2-0034" title="AgustiA , CalverleyPM , CelliB , CoxsonHO , EdwardsLD , LomasDA , et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respiratory Research2010;11:122. ">Agusti 2010</a>) and phenotypical variation in COPD (<a href="./references#CD006897-bbs2-0082" title="WeatherallM , TraversJ , ShirtcliffePM , MarshSE , WilliamsMV , NowitzMR , et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. European Respiratory Journal2009;34(4):812‐8. ">Weatherall 2009</a>) are increasingly recognised. COPD and asthma overlap syndrome are known to have a higher prevalence in older individuals and are associated with more frequent exacerbations (<a href="./references#CD006897-bbs2-0050" title="HardinM , ChoM , McDonaldML , BeatyT , RamsdellJ , BhattS , et al. The clinical and genetic features of COPD‐asthma overlap syndrome. European Respiratory Journal2014;44(2):341‐50. ">Hardin 2014</a>). </p> <p>COPD is an important and increasing cause of mortality; it was estimated to be the fifth leading cause of death in the year 2000 and was responsible for 2.75 million deaths (<a href="./references#CD006897-bbs2-0060" title="LopezAD , ShibuyaK , RaoC , MathersCD , HansellAL , HeldLS , et al. Chronic obstructive pulmonary disease: current burden and future projections. European Respiratory Journal2006;27(2):397‐412. ">Lopez 2006</a>). Worldwide mortality due to COPD is projected to rise to 4.5 million deaths in 2020, becoming the third leading cause (<a href="./references#CD006897-bbs2-0064" title="MurrayCJ , LopezAD . Alternative projections of mortality and disability by cause 1990‐2020: global burden of disease study. Lancet1997;349(9064):1498‐504. ">Murray 1997</a>). Worldwide COPD resulted in 16.5 million years of life lost in 2000, almost 10 million years lived with disability and 26.5 million disability‐adjusted life‐years (<a href="./references#CD006897-bbs2-0060" title="LopezAD , ShibuyaK , RaoC , MathersCD , HansellAL , HeldLS , et al. Chronic obstructive pulmonary disease: current burden and future projections. European Respiratory Journal2006;27(2):397‐412. ">Lopez 2006</a>). </p> <p>The Burden of Lung Disease (BOLD) study (<a href="./references#CD006897-bbs2-0037" title="BuistAS , McBurnieMA , VollmerWM , GillespieS , BurneyP , ManninoDM , et al. International variation in the prevalence of COPD (the BOLD study): a population‐based prevalence study. Lancet2007;370(9589):741‐50. ">Buist 2007</a>) reported a worldwide prevalence of stage II or greater severity (FEV<sub>1</sub> &lt; 80% predicted) of 10.1% (standard error (SE) 4.8) overall, 11.8% (SE 7.9) for men and 8.5% (SE 5.8) for women. International variation in the prevalence and severity of COPD is partially explained by variation in smoking prevalence and other risk factors (<a href="./references#CD006897-bbs2-0037" title="BuistAS , McBurnieMA , VollmerWM , GillespieS , BurneyP , ManninoDM , et al. International variation in the prevalence of COPD (the BOLD study): a population‐based prevalence study. Lancet2007;370(9589):741‐50. ">Buist 2007</a><i>)</i>. </p> <p>Exacerbations and co‐morbidities contribute to the varying natural history of COPD in individual patients (<a href="./references#CD006897-bbs2-0048" title="GOLD . Global Strategy for the Diagnosis, Management and Prevention of COPD, 2014. http://www.goldcopd.org/. ">GOLD 2014</a>)<i>.</i> Exacerbations contribute to long‐term decline in lung function (<a href="./references#CD006897-bbs2-0042" title="DonaldsonGC , SeemungalTA , BhowmikA , WedzichaJA . Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax2002;57(10):847‐52. ">Donaldson 2002</a>) and reduced physical activity (<a href="./references#CD006897-bbs2-0043" title="DonaldsonGC , WilkinsonTMA , HurstJR , PereraWR , WedzichaJA . Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine2005;171:446‐52. ">Donaldson 2005</a><i>)</i> and are associated with increased risk of death (<a href="./references#CD006897-bbs2-0075" title="Soler‐CatalunaJJ , Martinnez‐GarciaMA , Roman SanchezP , SalcedoE , NavarroM , OchandoR . Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax2005;60(11):925‐31. ">Soler‐Cataluna 2005</a>). They also have a profound and long‐lasting effect on quality of life (<a href="./references#CD006897-bbs2-0049" title="GroenewegenK , ScholsA , WoutersE . Prognosis after hospitalization for acute exacerbations of COPD. European Respiratory Journal2001;8(Suppl 33):209s. ">Groenewegen 2001</a>; <a href="./references#CD006897-bbs2-0084" title="WilkinsonTM , DonaldsonGC , HurstJR , SeemungalTA , WedzichaJA . Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine2004;169(12):1298‐303. ">Wilkinson 2004</a>); in 10% of exacerbations, pre‐exacerbation quality of life was not recovered after three months (<a href="./references#CD006897-bbs2-0071" title="SeemungalTA , DonaldsonGC , BhowmikA , JeffriesDJ , WedzichaJA . Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine2000;161(5):1608‐13. ">Seemungal 2000</a>). </p> <p>Exacerbations of COPD are a frequent cause of hospitalisation (<a href="./references#CD006897-bbs2-0044" title="DonaldsonGC , WedzichaJA . COPD exacerbations 1: epidemiology. Thorax2006;61:164‐8. ">Donaldson 2006</a>), although exacerbations with less severe symptoms and signs are often managed on an outpatient basis (<a href="./references#CD006897-bbs2-0065" title="National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care [update 2010]. http://guidance.nice.org.uk/CG101 (accessed 18 July 2011). ">NICE 2010</a>). Hospital‐at‐home or early discharge services, if available, may be used as an alternative way of caring for patients with exacerbations of COPD who otherwise would need to be admitted or to remain in hospital (<a href="./references#CD006897-bbs2-0065" title="National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care [update 2010]. http://guidance.nice.org.uk/CG101 (accessed 18 July 2011). ">NICE 2010</a>). Treatment of patients with exacerbations is a large contributor to the economic burden of COPD (<a href="./references#CD006897-bbs2-0070" title="SchermerT , ChavannesN , SarisC , AkkermansR , vanSchayckC , vanWeelC . Exacerbations and associated health care cost in patients with chronic obstructive pulmonary disease in general practice. Results from the COOPT trial. European Respiratory Journal2002;20(Suppl 38):398s. ">Schermer 2002</a>; <a href="./references#CD006897-bbs2-0077" title="SullivanSD , RamseySD , LeeTA . The economic burden of COPD. Chest2000;117:5s‐9s. ">Sullivan 2000</a>), and a high proportion of costs is due to hospitalisation (<a href="./references#CD006897-bbs2-0066" title="OostenbrinkJB , Rutten‐van MolkenMP . Resource use and risk factors in high‐cost exacerbations of COPD. Respiratory Medicine2004;98:883‐91. ">Oostenbrink 2004</a>). </p> <p>Studies on the frequency of exacerbations usually use an “event‐based” definition based on healthcare utilization (<a href="./references#CD006897-bbs2-0045" title="EffingTW , KerstjensHAM , MonninkhofEM , van derValkPDLPM , WoutersEFM , PostmaDS , et al. Definitions of exacerbations: does it really matter in clinical trials on COPD?. Chest2009;136(3):918‐23. ">Effing 2009</a>), and different events may be a proxy for severity, with unscheduled clinic or emergency room visits rated “moderate,” and those requiring hospitalisation labelled “severe” (<a href="./references#CD006897-bbs2-0069" title="Rodriguez‐RoisinR . Toward a consensus definition for COPD exacerbations. Chest2000;117(5 Suppl 2):398S‐401S. ">Rodriguez‐Roisin 2000</a>). However, the clinical onset of an acute exacerbation is defined according to symptoms, although no universally agreed upon definition is known (<a href="./references#CD006897-bbs2-0069" title="Rodriguez‐RoisinR . Toward a consensus definition for COPD exacerbations. Chest2000;117(5 Suppl 2):398S‐401S. ">Rodriguez‐Roisin 2000</a>). Type 1 exacerbations were originally defined by Anthonisen on the basis of three major symptoms: increased dyspnoea, sputum volume and sputum purulence; type 2 exacerbations were associated with only two of the major symptoms, and type 3 exacerbations involved one major symptom plus cough, wheeze or symptoms of an upper respiratory tract infection (<a href="./references#CD006897-bbs2-0035" title="AnthonisenNR , ManfredaJ , WarrenCP , HershfieldES , HardingGK , NelsonNA . Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Annals of Internal Medicine1987;106(2):196‐204. ">Anthonisen 1987</a>). A later definition required an increase in two of the "major symptoms" of dyspnoea—sputum volume or sputum purulence—or in one major symptom and one "minor symptom" (wheeze, sore throat, cough or common cold symptoms) for two days (<a href="./references#CD006897-bbs2-0071" title="SeemungalTA , DonaldsonGC , BhowmikA , JeffriesDJ , WedzichaJA . Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine2000;161(5):1608‐13. ">Seemungal 2000</a>). More recently, a standardised measure for assessing frequency, severity and duration of exacerbations of COPD using patient‐reported outcomes has been developed for use in clinical studies: the EXACT (exacerbations of chronic pulmonary disease tool) diary, which consists of 14 items (<a href="./references#CD006897-bbs2-0056" title="LeidyNK , WilcoxTK , JonesPW , MurrayL , WinnetteR , HowardK , et al. Development of the EXAcerbations of chronic obstructive pulmonary disease Tool (EXACT): a patient‐reported outcome (PRO) measure. Value in Health2010;13(8):965‐75. ">Leidy 2010</a>; <a href="./references#CD006897-bbs2-0057" title="LeidyNK , WilcoxTK , JonesPW , RobertsL , PowersJH , SethiS . Standardizing measurement of chronic obstructive pulmonary disease exacerbations. American Journal of Respiratory and Critical Care Medicine2011;183(3):323‐9. ">Leidy 2011</a>). </p> <p>The inflammatory mechanisms underlying the onset and development of COPD exacerbations are complex (<a href="./references#CD006897-bbs2-0036" title="BathoornE , KerstjensH , PostmaD , TimensW , MacNeeW . Airways inflammation and treatment during acute exacerbations of COPD. International Journal of Chronic Obstructive Pulmonary Disease2008;3(2):217‐29. ">Bathoorn 2008</a>), and exacerbations can be precipitated by several factors, and the most common causes are infective (<a href="./references#CD006897-bbs2-0067" title="PapiA , BellettatoCM , BraccioniF , RomagnoliM , CasolariP , CaramoriG , et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. American Journal of Respiratory and Critical Care Medicine2006;173(10):1114‐21. ">Papi 2006</a>); bacterial pathogens are identified in just over 50% of cases, and viral causes in around 25% (<a href="./references#CD006897-bbs2-0072" title="SethiS , EvansN , GrantBJ , MurphyTF . New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. New England Journal of Medicine2002;347(7):465‐71. ">Sethi 2002</a>; <a href="./references#CD006897-bbs2-0074" title="SherkPA , GrossmanRF . The chronic obstructive pulmonary disease exacerbation. Clinics in Chest Medicine2000;21(4):705‐21. ">Sherk 2000</a>). Non‐infective causes such as air pollution and other environmental conditions that increase airway inflammation may account for 15% to 20% of exacerbations (<a href="./references#CD006897-bbs2-0073" title="SethiS , MurphyTF . Infection in the pathogenesis and course of chronic obstructive pulmonary disease. New England Journal of Medicine2008;359(22):2355‐65. ">Sethi 2008</a>). Exacerbations become more frequent and more severe as the severity of COPD increases (<a href="./references#CD006897-bbs2-0076" title="SuissaS , Dell'AnielloS , ErnstP . Long‐term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax2012;67(11):957‐63. ">Suissa 2012</a>), although the rate at which they occur may reflect an independent susceptibility phenotype—the “frequent exacerbator” (<a href="./references#CD006897-bbs2-0053" title="HurstJR , VestboJ , AnzuetoA , LocantoreN , MullerovaH , Tal‐SingerR , et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. New England Journal of Medicine2010;363(12):1128‐38. ">Hurst 2010</a>). </p> </section> <section id="CD006897-sec-0032"> <h3 class="title" id="CD006897-sec-0032">Description of the intervention</h3> <p>The acute inflammatory response to airway infection is influenced by both pathogenic and host factors, resulting in increased airway and systemic inflammation (<a href="./references#CD006897-bbs2-0073" title="SethiS , MurphyTF . Infection in the pathogenesis and course of chronic obstructive pulmonary disease. New England Journal of Medicine2008;359(22):2355‐65. ">Sethi 2008</a>). Airway inflammation is significantly increased during exacerbations of COPD, and evidence of increased numbers of neutrophils, lymphocytes and eosinophils is seen in airways and in sputum (<a href="./references#CD006897-bbs2-0047" title="FalkJA , MinaiOA , MosenifarZ . Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society2008;5(4):506‐12. ">Falk 2008</a>; <a href="./references#CD006897-bbs2-0067" title="PapiA , BellettatoCM , BraccioniF , RomagnoliM , CasolariP , CaramoriG , et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. American Journal of Respiratory and Critical Care Medicine2006;173(10):1114‐21. ">Papi 2006</a>). Systemic inflammation is also present in COPD; many circulating inflammatory mediators are elevated, both in stable COPD and during exacerbations. C‐reactive protein (CRP) is a known marker of systemic inflammation whose levels are elevated during exacerbations; it is a likely participant in the inflammatory cascade (<a href="./references#CD006897-bbs2-0047" title="FalkJA , MinaiOA , MosenifarZ . Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease. Proceedings of the American Thoracic Society2008;5(4):506‐12. ">Falk 2008</a>). Theoretical mechanisms for clinical improvement in lung function among patients treated with corticosteroids during exacerbations may include reduction in airway inflammation or a decrease in airway oedema (<a href="./references#CD006897-bbs2-0083" title="WedzichaJA . Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease. Thorax2000;55(Suppl 1):S23‐7. ">Wedzicha 2000</a>)<i>.</i> </p> </section> <section id="CD006897-sec-0033"> <h3 class="title" id="CD006897-sec-0033">Why it is important to do this review</h3> <p>Systemic corticosteroid use in COPD is associated with potential adverse drug effects, including fluid retention, hypertension, diabetes mellitus, adrenal suppression and osteoporosis (<a href="./references#CD006897-bbs2-0062" title="McEvoyCE , NiewoehnerDE . Adverse effects of corticosteroid therapy for COPD. Chest1997;111:732‐43. ">McEvoy 1996</a>). Fracture risk is increased (<a href="./references#CD006897-bbs2-0038" title="DeVriesF , BrackeM , LeufkensHGM , LammersJWJ , CooperC , VanStaaTP . Fracture risk with intermittent high‐dose oral glucocorticoid therapy. Arthritis and Rheumatism2007;56(1):208‐14. ">De Vries 2007</a>; <a href="./references#CD006897-bbs2-0079" title="VestergaardP , RejnmarkL , MosekildeL . Fracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroids. Chest2007;132(5):1599‐607. [PUBMED: 17890464 ] ">Vestergaard 2007</a>); this is potentially important, as the rate of existing vertebral compression fractures in the COPD population experiencing acute exacerbations, especially among older people with longer duration of disease, is high (<a href="./references#CD006897-bbs2-0061" title="MajumdarSR , Villa‐RoelC , LyonsKJ , RoweBH . Prevalence and predictors of vertebral fracture in patients with chronic obstructive pulmonary disease. Respiratory Medicine2010;104(2):260‐6. ">Majumdar 2010</a>). Short‐term use of systemic corticosteroids in the treatment of patients with exacerbations of COPD also has adverse effects on respiratory and peripheral muscle strength (<a href="./references#CD006897-bbs2-0039" title="DecramerM , LacquetLM , FagardR , RogiersP . Corticosteroids contribute to muscle weakness in chronic airflow obstruction. American Journal of Respiratory and Critical Care Medicine1994;150(1):11‐6. ">Decramer 1994</a>). The risk of adverse drug effects of systemic corticosteroids in COPD rises with increasing frequency of high‐dose systemic corticosteroid use and with increasing cumulative exposure (more than 1 g) (<a href="./references#CD006897-bbs2-0038" title="DeVriesF , BrackeM , LeufkensHGM , LammersJWJ , CooperC , VanStaaTP . Fracture risk with intermittent high‐dose oral glucocorticoid therapy. Arthritis and Rheumatism2007;56(1):208‐14. ">De Vries 2007</a>). </p> <p>Systemic corticosteroid treatment of patients with acute exacerbations of COPD decreases treatment failure and is associated with early improvement in lung function, breathlessness and arterial hypoxaemia and reduced length of hospital stay (<a href="./references#CD006897-bbs2-0081" title="WaltersJAE , TanDJ , WhiteCJ , GibsonPG , Wood‐BakerR , WaltersEH . Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews2014, Issue 9. [DOI: 10.1002/14651858.CD001288.pub4] ">Walters 2014</a>), although in this Cochrane review, the duration of systemic corticosteroid treatment varied, usually described as between three days and 15 days. Guidelines for the management of COPD specify a duration of treatment ranging from seven days to 10 days (<a href="./references#CD006897-bbs2-0048" title="GOLD . Global Strategy for the Diagnosis, Management and Prevention of COPD, 2014. http://www.goldcopd.org/. ">GOLD 2014</a>), from seven days to 14 days (<a href="./references#CD006897-bbs2-0065" title="National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care [update 2010]. http://guidance.nice.org.uk/CG101 (accessed 18 July 2011). ">NICE 2010</a>) and from 10 days to 14 days (<a href="./references#CD006897-bbs2-0063" title="McKenzieDK , FrithPA , BurdonJG , TownGI . The COPDX Plan: Australian and New Zealand guidelines for the management of chronic obstructive pulmonary disease 2003. Medical Journal of Australia2003;178(Suppl):S7‐S39. ">McKenzie 2003</a>). Thus, it is important to define the optimum duration of corticosteroid treatment and to take into account limiting potential adverse effects. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD006897-sec-0034" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD006897-sec-0034"></div> <p>To compare the efficacy of short‐duration (seven or fewer days) and conventional longer‐duration (longer than seven days) systemic corticosteroid treatment of adults with acute exacerbations of COPD. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD006897-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD006897-sec-0035"></div> <section id="CD006897-sec-0036"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD006897-sec-0037"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) comparing short‐duration systemic corticosteroid treatment (seven or fewer days) versus conventional, longer‐duration treatment (longer than seven days). </p> </section> <section id="CD006897-sec-0038"> <h4 class="title">Types of participants</h4> <p>Adults with an acute exacerbation of COPD. The definition of an acute exacerbation could include any combination of an increase in breathlessness, sputum volume, sputum purulence, cough or wheeze. We excluded studies that included patients with asthma and other lung diseases (e.g. interstitial lung disease, bronchiectasis), unless separate data on participants with COPD alone were available. </p> </section> <section id="CD006897-sec-0039"> <h4 class="title">Types of interventions</h4> <p>Systemic corticosteroid (SCS) given for a period of seven or fewer days (SCS ≤ 7) versus systemic corticosteroid given for longer than seven days (SCS &gt; 7). Co‐interventions were required to be standardised across groups. We excluded studies in which participants received assisted ventilation (invasive or non‐invasive). </p> </section> <section id="CD006897-sec-0040"> <h4 class="title">Types of outcome measures</h4> <section id="CD006897-sec-0041"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD006897-list-0001"> <li> <p>Treatment failure (e.g. the need for additional treatment, hospital admission/re‐admission for index episode, return to emergency department, unscheduled physician visit for the index episode). </p> </li> <li> <p>Relapse after treatment (e.g. treatment for new acute exacerbation, re‐admission or hospitalisation for COPD). </p> </li> <li> <p>Adverse drug effects.</p> </li> </ol> </p> </section> <section id="CD006897-sec-0042"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD006897-list-0002"> <li> <p>Mortality.</p> </li> <li> <p>Lung function.</p> </li> <li> <p>Length of hospital stay.</p> </li> <li> <p>Arterial blood gases.</p> </li> <li> <p>Symptom scores.</p> </li> <li> <p>Quality of life.</p> </li> </ol> </p> <p>Time period for assessment of continuous outcomes: Early response was measured on or before day seven of treatment, and end of treatment response measurements were made at the time point equivalent to the end of the longer treatment period. </p> </section> </section> </section> <section id="CD006897-sec-0043"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD006897-sec-0044"> <h4 class="title">Electronic searches</h4> <p>We identified trials from the Cochrane Airways Trials Register, which is maintained by the Information Specialist for the Group. The Cochrane Airways Trials Register contains studies identified from several sources: </p> <p> <ol id="CD006897-list-0003"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL), through the Cochrane Register of Studies Online (crso.cochrane.org); </p> </li> <li> <p>Weekly searches of MEDLINE Ovid SP 1946 to date;</p> </li> <li> <p>Weekly searches of Embase Ovid SP 1974 to date;</p> </li> <li> <p>Monthly searches of PsycINFO Ovid SP 1967 to date;</p> </li> <li> <p>Monthly searches of CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature) 1937 to date; </p> </li> <li> <p>Monthly searches of AMED EBSCO (Allied and Complementary Medicine);</p> </li> <li> <p>Handsearches of the proceedings of major respiratory conferences.</p> </li> </ol> </p> <p>Studies contained in the Trials Register are identified through search strategies based on the scope of Cochrane Airways. Details of these strategies, as well as a list of handsearched conference proceedings are in <a href="./appendices#CD006897-sec-0093">Appendix 1</a>. </p> <p>We conducted additional supplementary searches of MEDLINE (PubMed platform, dates covered 1950 to March 2017) and CENTRAL (2017, Issue 3). EMBASE (Embase.com platform, dates covered 1947 to July 2014) searches were conducted in previous versions of this review.. Search strategies used in the Cochrane Airways Register of Trials and other databases are shown in <a href="./appendices#CD006897-sec-0099">Appendix 2</a>. </p> <p>For this review update, searches were conducted in the Cochrane Airways Group Register of Trials, and in the other databases in March 2017. </p> </section> <section id="CD006897-sec-0045"> <h4 class="title">Searching other resources</h4> <p>Bibliographies of RCTs and review articles identified for inclusion were searched for additional papers. Registers of ongoing trials at Clinicaltrials.gov and the WHO trial portal were searched in March 2017. </p> </section> </section> <section id="CD006897-sec-0046"> <h3 class="title" id="CD006897-sec-0046">Data collection and analysis</h3> <section id="CD006897-sec-0047"> <h4 class="title">Selection of studies</h4> <p>All potentially relevant trials were assessed for relevance by at least two review authors (DT, CW), who screened the full text to independently select trials for inclusion and to identify and record reasons for exclusion of ineligible studies. We resolved disagreements through discussion or, if required, we consulted a third person (JW). We identified and excluded duplicates and collated multiple reports of the same study, so that each study (rather than each report) was the unit of interest in the review. We recorded the selection process as a PRISMA flow diagram and in the <a href="./references#CD006897-sec-0110" title="">Characteristics of excluded studies</a> table. </p> <p>We initially screened all studies using the following criteria.</p> <p> <ol id="CD006897-list-0004"> <li> <p>Acute exacerbation of COPD?</p> </li> <li> <p>Systemic corticosteroids as intervention?</p> </li> <li> <p>Comparison of short‐duration (seven or fewer days) versus longer‐duration (longer than seven days) corticosteroid therapy? </p> </li> <li> <p>Randomised controlled trial?</p> </li> </ol> </p> <p>We noted other arms and reasons for study exclusion when appropriate. We determined exclusion using the criteria listed above and categorised the following as applicable. </p> <p> <ol id="CD006897-list-0005"> <li> <p>Not different durations of steroids.</p> </li> <li> <p>Not exacerbations of COPD.</p> </li> <li> <p>Not treatment with systemic corticosteroids.</p> </li> <li> <p>Review or other type of article.</p> </li> </ol> </p> <p>We also assessed each study for accuracy of the diagnosis of COPD using the following criteria (<a href="./references#CD006897-bbs2-0048" title="GOLD . Global Strategy for the Diagnosis, Management and Prevention of COPD, 2014. http://www.goldcopd.org/. ">GOLD 2014</a>). </p> <p> <ol id="CD006897-list-0006"> <li> <p>Did the patient have dyspnoea, chronic cough or sputum production?</p> </li> <li> <p>Was there a history of exposure to risk factors including tobacco smoke; occupational dusts and chemicals; and smoke from home cooking and heating fuel? </p> </li> <li> <p>Was a spirometry measurement of the FEV<sub>1</sub>/FVC ratio less than 0.7 post bronchodilator? </p> </li> </ol> </p> </section> <section id="CD006897-sec-0048"> <h4 class="title">Data extraction and management</h4> <p>We used a data collection form to document study characteristics and outcome data. Two review authors (DT, CW) extracted the following study characteristics from included studies. </p> <p> <ol id="CD006897-list-0007"> <li> <p>Methods: study design, total duration of study, number of study centres and locations, study setting, withdrawals and date of study. </p> </li> <li> <p>Participants: N, mean age, age range, gender, COPD diagnostic criteria, diagnostic criteria for exacerbation, baseline lung function, smoking history, inclusion criteria and exclusion criteria. </p> </li> <li> <p>Interventions: systemic corticosteroid treatment dose/schedule, concomitant medications and excluded medications. </p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected and time points reported.</p> </li> <li> <p>Notes: funding for trial and notable conflicts of interest of trial authors.</p> </li> </ol> </p> <p>Two review authors (two of JW, DT, CW) independently extracted outcome data from included studies. Results presented in graphical form were extracted using the software Plot Digitizer. When results were available as means with interquartile ranges, standard deviation was based on the width of the interquartile range—approximately 1.35. standard deviations. </p> <p>Data were entered into Review Manager (by JW, DT, CW) and were double‐checked by a second review author. We checked that data were entered correctly by comparing data presented in the systematic review against data provided in the study reports. </p> </section> <section id="CD006897-sec-0049"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (of JW, CW, DT) independently assessed the risk of bias for each study using the criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions (<a href="./references#CD006897-bbs2-0052" title="HigginsJ , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). We resolved disagreements by discussion or by involving another review author. We assessed risk of bias according to the following domains. </p> <p> <ol id="CD006897-list-0008"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Incomplete outcome data.</p> </li> <li> <p>Selective outcome reporting.</p> </li> <li> <p>Presence of other bias(es).</p> </li> </ol> </p> <p>We graded each potential source of bias as high, low or unclear, and provided a quote from the study report, together with a justification for our judgement, in the 'Risk of bias' table. We summarised risk of bias judgements across different studies for each of the domains listed. When information on risk of bias was related to unpublished data or correspondence with a trialist, we noted this in the 'Risk of bias' table. </p> <p>When considering treatment effects, we took into account the risk of bias for studies that contributed to this outcome. </p> </section> <section id="CD006897-sec-0050"> <h4 class="title">Measures of treatment effect</h4> <p>For continuous variables, data were analysed as mean differences (MDs) with 95% confidence intervals (CIs). Standardised mean differences (SMDs) with 95% CIs were used when different scales of measurement had been used for an outcome. The SMD is a statistic that expresses the difference in means between treatment groups in units of the pooled standard deviation. Dichotomous outcomes were analysed using Mantel‐Haenszel odds ratios with 95% CIs. When events were rare, we employed the Peto odds ratio. Scale data were entered with a consistent direction of effect. </p> <p>We undertook meta‐analyses only when these were meaningful—when treatments, participants and the underlying clinical question were similar. When data were skewed, we described them narratively. </p> <p>For 'time‐to‐event' outcomes such as log hazard ratios, the fixed‐effect generic inverse variance outcome was used to combine results. This method provides a weighted average of the effect estimates of separate studies (<a href="./references#CD006897-bbs2-0052" title="HigginsJ , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). Number needed to treat for an additional beneficial outcome was calculated from the pooled odds ratio and its confidence interval, using baseline risk in the control group. </p> </section> <section id="CD006897-sec-0051"> <h4 class="title">Unit of analysis issues</h4> <p>We analysed dichotomous data using participants as the unit of analysis. For continuous data, the MD based on change from baseline was preferred over the MD based on absolute values when both were available. </p> </section> <section id="CD006897-sec-0052"> <h4 class="title">Dealing with missing data</h4> <p>We contacted investigators to obtain missing numerical outcome data when possible (e.g. when a study was reported as an abstract only). When this was not possible, and when missing data were thought to introduce serious bias, we performed a sensitivity analysis to explore the impact of including such studies in the overall assessment of results. </p> </section> <section id="CD006897-sec-0053"> <h4 class="title">Assessment of heterogeneity</h4> <p>An assessment of possible heterogeneity, when the null hypothesis is that all studies are evaluating the same effect, was carried out for pooled effects using a Breslow‐Day test of heterogeneity; the Chi<sup>2</sup> test measures the deviation of observed effect sizes from an underlying overall effect. This test has low power for detecting true heterogeneity when studies have small sample size or are few in number, hence we used a P value of 0.10 (<a href="./references#CD006897-bbs2-0040" title="DeeksJJ , HigginsJPT , AltmanDG . Chapter 9: Analysing data and undertaking meta‐analyses. In: HigginsJPT , GreenS editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. www.cochrane‐handbook.org. The Cochrane Collaboration, 2008. ">Deeks 2008</a>). In addition, the I<sup>2</sup> statistic, which describes the percentage of total variation across studies that is due to heterogeneity rather than to chance (<a href="./references#CD006897-bbs2-0051" title="HigginsJPT , ThompsonSG , DeeksJD , AltmanG . Measuring inconsistency in meta‐analysis. BMJ2003;327:557‐60. ">Higgins 2003</a>), was used. Statistical heterogeneity was interpreted as follows: 0% to 40% might not be important, 30% to 60% may represent moderate heterogeneity and 50% to 90% may represent substantial heterogeneity (<a href="./references#CD006897-bbs2-0052" title="HigginsJ , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>We assessed clinical and methodological heterogeneity by recording differences in study design and participant characteristics between individual studies. When we found substantial heterogeneity, we reported this and explored possible causes by performing prespecified subgroup analysis. </p> </section> <section id="CD006897-sec-0054"> <h4 class="title">Assessment of reporting biases</h4> <p>We tried to minimise reporting bias from non‐publication of studies or selective outcome reporting by using a broad search strategy. We checked references of included studies and relevant systematic reviews, and we contacted study authors to request additional outcome data. To assess the presence of publication bias, we visually inspected funnel plots when 10 or more studies contributed to the analysis for a specified outcome. </p> </section> <section id="CD006897-sec-0055"> <h4 class="title">Data synthesis</h4> <p>Data were pooled using Review Manager 5.3 (<a href="./references#CD006897-bbs2-0068" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used a fixed‐effect model, and when heterogeneity could not be explained, we performed a sensitivity analysis using a random‐effects model. We presented the findings of our primary outcomes in a 'Summary of findings' table according to recommendations provided in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD006897-bbs2-0052" title="HigginsJ , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>) (generated with the use of GradePro software). </p> </section> <section id="CD006897-sec-0056"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>When we detected statistically significant heterogeneity (P value &lt; 0.10), several options were available. We explored the clinical diversity of studies through prespecified subgroup analyses by comparing the following factors. </p> <p> <ol id="CD006897-list-0009"> <li> <p>Definition of COPD.</p> </li> <li> <p>Aspects of study quality (e.g. concealment of allocation).</p> </li> <li> <p>Characteristics of participants.</p> </li> </ol> </p> <p>We considered random‐effects analysis methods (<a href="./references#CD006897-bbs2-0041" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7:177‐88. ">DerSimonian 1986</a>) when heterogeneity was unexplained and study sizes were large, or when study findings were not pooled. </p> <p>We performed subgroup analyses, stratified by the following variables, when possible.</p> <p> <ol id="CD006897-list-0010"> <li> <p>Inpatient versus outpatient.</p> </li> <li> <p>Studies that included participants previously treated with corticosteroids (inhaled and systemic). </p> </li> </ol> </p> </section> <section id="CD006897-sec-0057"> <h4 class="title">Sensitivity analysis</h4> <p>In assessment of heterogeneity, possible causes arising from details of study design were considered. Sensitivity analyses were performed using a random‐effects model versus a fixed‐effect model for risk of bias and other potential confounders. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD006897-sec-0058" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD006897-sec-0058"></div> <section id="CD006897-sec-0059"> <h3 class="title">Description of studies</h3> <section id="CD006897-sec-0060"> <h4 class="title">Results of the search</h4> <p>Of 644 unique records obtained in the 2011 searches (<a href="#CD006897-fig-0001">Figure 1</a>), seven studies met the inclusion criteria, of which four reported data and contributed to the original meta‐analysis (<a href="./references#CD006897-bbs2-0080" title="WaltersJA , WangW , MorleyC , SoltaniA , Wood‐BakerR . Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD006897.pub2] ">Walters 2011</a>). One ongoing study (<a href="./references#CD006897-bbs2-0033" title="ReidD , SoltaniA , Wood‐BakerR , WaltersEH . Personal correspondence2010. ">Reid 2010</a>) suspended recruitment in 2010, but no data are available. Searches from 2011 to 2014 yielded 284 results in the Cochrane Airways Group Register of Trials, 39 results in CINAHL, 168 in EMBASE and 102 in CENTRAL. When the inclusion criteria were applied, one new study was identified for inclusion (<a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>), which was listed as an ongoing trial in 2011. </p> <div class="figure" id="CD006897-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="1 Study flow diagram." data-id="CD006897-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>1 Study flow diagram.</p> </div> </div> </div> <p>In March 2017, we ran an update search. This returned 417 references of which 13 were duplicate, 390 were judged as irrelevant based on title and abstract alone. 14 full text articles were assessed, 13 excluded (<b>7</b> Wrong intervention, <b>4</b> Wrong comparator, <b>2</b> Wrong study design), 1 citation belonged to an already included study (Leuppi 2013). </p> <p>One on‐going study was identified as of March 2017 (Leuppi 2017).</p> </section> <section id="CD006897-sec-0061"> <h4 class="title">Included studies</h4> <p>We have provided details of the eight included studies in the <a href="./references#CD006897-sec-0109" title="">Characteristics of included studies</a> table and a comparison of their main inclusion criteria and characteristics in <a href="#CD006897-tbl-0002">Table 1</a>. </p> <div class="table" id="CD006897-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study characteristics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID/Setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Inclusion criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>AE definition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N participants included/Completing</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean age, years</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>% males/ % smokers</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Prestudy SCS use, %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SCS ≤ 7 days</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SCS &gt; 7 days</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Definition of treatment failure</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a> China/ inpatients </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years of continuous productive cough, FEV<sub>1</sub>/FVC post BD &lt; 0.7, FEV<sub>1</sub> &lt; 80% predicted. No respiratory failure, diabetes or bronchial asthma </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At least 2 of 3 symptoms: increased sputum or dyspnoea or purulent sputum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75/44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg/d 10 days + 15 mg/d 5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not known</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0002" title="GomaaM , FaramawyM , IbrahimH . Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]. European Respiratory Society 18th Annual Congress; 2008 Oct 3‐7; Berlin. 2008:[P3601]. ">Gomaa 2008</a> (abstract only) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub> &lt; 50% predicted, no respiratory acidosis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42/Not known</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 15 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a> Switzerland/5 sites </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Age &gt; 40 years, smoking history ≥ 20 pack‐years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At least 2 of the following: change in baseline dyspnoea, cough or sputum quantity/purulence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>314/296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60/45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 days: days 1 to 4 methylprednisolone 40 mg, days 2 to 5 oral prednisolone 40 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14 days: days 1 to 4 methylprednisolone 40 mg, days 2 to 14 oral 40 mg prednisolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Received open‐label glucocorticoids during index exacerbation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0004" title="Abdullah Al MamunSM , RahmanS . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Thorax2011;66(Suppl 4):A172. RahmanM , AbdullahA , MamunSM , HaqueMD . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Chest2004;126(4 Suppl):839S‐a. ">Rahman 2004</a> (abstract only) Bangladesh/1 site </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 14 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0005" title="SalamT , AkersSM , LotanoR , ArnoldGK , BartterT , PratterMR , et al. Optimal duration of corticosteroid therapy in the treatment of exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1998;157(3 Suppl):A801. ">Salam 1998</a> (abstract only) USA/Unknown sites </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/Not known</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None in previous month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IV CS 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IV CS 3 days + 7 days OCS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a> Turkey/1 site </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub> &lt; 35% predicted, PYH &gt; 20, no respiratory failure requiring ventilation </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated, requiring admission</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36/34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94/Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None in previous month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IV methylprednisone 0.5 mg/kg qds 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IV methylprednisone 0.5 mg/kg qds 3 days, bd 3 days, od 4 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required open‐label steroid treatment</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0007" title="SirichanaW , SittipuntC , KawkitinarongK , WongtimS . Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology2008;13(Suppl 5):A120 [012‐01]. ">Sirichana 2008</a> (abstract and author data) Thailand/1 site </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Age &gt; 40 years, symptoms &gt; 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increase in at least 2 of 3 symptoms—dyspnoea, sputum volume, sputum purulence; requiring admission </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48/42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88/Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None in previous month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 10 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a> (abstract and author data) Australia &amp; New Zealand/2 sites </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Age &gt; 40 years; &gt; 10 pack‐year smoking history; FEV<sub>1</sub> &lt; 50% predicted </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated, requiring admission</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38/28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63/Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None for current AEs, no long‐term OS &gt; 5 mg/d</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 2.5 mg/kg orally daily for 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 0.6 mg/kg orally daily for 7 days followed by prednisolone 0.3 mg/kg orally daily for 7 days </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lack of progress according to attending physician during treatment</p> </td> </tr> </tbody> </table> </div> <p>All eight studies with a total of 582 participants were parallel‐group RCTs comparing systemic corticosteroid treatment for seven or fewer days versus treatment for longer than seven days in people with an acute exacerbation of COPD; all were conducted in hospital settings. These studies were published between 1997 and 2013. Two studies reported the definition for COPD diagnosis (<a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a>; <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>), and two studies specified the inclusion of participants with an FEV<sub>1</sub> below 50% predicted (<a href="./references#CD006897-bbs2-0002" title="GomaaM , FaramawyM , IbrahimH . Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]. European Respiratory Society 18th Annual Congress; 2008 Oct 3‐7; Berlin. 2008:[P3601]. ">Gomaa 2008</a>; <a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>) or below 35% predicted (<a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a>). Two studies (<a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>; <a href="./references#CD006897-bbs2-0007" title="SirichanaW , SittipuntC , KawkitinarongK , WongtimS . Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology2008;13(Suppl 5):A120 [012‐01]. ">Sirichana 2008</a>) provided a specific symptom‐based definition of an acute exacerbation. </p> <p>Studies varied in size from 21 to 314 participants; the mean age of participants was between 65 and 73 years, and the proportion of female participants ranged from 6% to 42% (in four studies that reported these data). Participants had severe to very severe COPD; in two studies baseline mean FEV<sub>1</sub> ranged from 0.5 to 0.8 litres, and in two other studies baseline mean FEV<sub>1</sub> ranged from 25% to 33% predicted. </p> <p>Five studies used only oral prednisolone (<a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a>; <a href="./references#CD006897-bbs2-0002" title="GomaaM , FaramawyM , IbrahimH . Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]. European Respiratory Society 18th Annual Congress; 2008 Oct 3‐7; Berlin. 2008:[P3601]. ">Gomaa 2008</a>; <a href="./references#CD006897-bbs2-0004" title="Abdullah Al MamunSM , RahmanS . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Thorax2011;66(Suppl 4):A172. RahmanM , AbdullahA , MamunSM , HaqueMD . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Chest2004;126(4 Suppl):839S‐a. ">Rahman 2004</a>; <a href="./references#CD006897-bbs2-0007" title="SirichanaW , SittipuntC , KawkitinarongK , WongtimS . Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology2008;13(Suppl 5):A120 [012‐01]. ">Sirichana 2008</a>; <a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>) at a dose of 30 mg daily, except <a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>, which provided oral prednisolone 2.5 mg/kg in the short‐duration arm and a tapered dose (0.6 mg/kg/d for seven days followed by 0.3 mg/kg/d for seven days) in the longer‐duration arm. Three studies used intravenous corticosteroid initially in both arms for 24 or 72 hours: methylprednisolone in <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a> and <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a>, and an unspecified intravenous corticosteroid in <a href="./references#CD006897-bbs2-0005" title="SalamT , AkersSM , LotanoR , ArnoldGK , BartterT , PratterMR , et al. Optimal duration of corticosteroid therapy in the treatment of exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1998;157(3 Suppl):A801. ">Salam 1998</a>. Participants then received systemic corticosteroids intravenously for seven days in <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a> and orally for seven days in <a href="./references#CD006897-bbs2-0005" title="SalamT , AkersSM , LotanoR , ArnoldGK , BartterT , PratterMR , et al. Optimal duration of corticosteroid therapy in the treatment of exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1998;157(3 Suppl):A801. ">Salam 1998</a> in the longer‐duration arm. All participants in <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a> received oral prednisone from day 2 onwards for the appropriate treatment duration. </p> <p>Duration of treatment in the short‐course arm was three days in <a href="./references#CD006897-bbs2-0005" title="SalamT , AkersSM , LotanoR , ArnoldGK , BartterT , PratterMR , et al. Optimal duration of corticosteroid therapy in the treatment of exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1998;157(3 Suppl):A801. ">Salam 1998</a>, <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a> and <a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>; five days in <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a> and <a href="./references#CD006897-bbs2-0007" title="SirichanaW , SittipuntC , KawkitinarongK , WongtimS . Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology2008;13(Suppl 5):A120 [012‐01]. ">Sirichana 2008</a>; and seven days in <a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a>, <a href="./references#CD006897-bbs2-0002" title="GomaaM , FaramawyM , IbrahimH . Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]. European Respiratory Society 18th Annual Congress; 2008 Oct 3‐7; Berlin. 2008:[P3601]. ">Gomaa 2008</a> and <a href="./references#CD006897-bbs2-0004" title="Abdullah Al MamunSM , RahmanS . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Thorax2011;66(Suppl 4):A172. RahmanM , AbdullahA , MamunSM , HaqueMD . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Chest2004;126(4 Suppl):839S‐a. ">Rahman 2004</a>. The duration of longer‐course treatment was 10 days in <a href="./references#CD006897-bbs2-0005" title="SalamT , AkersSM , LotanoR , ArnoldGK , BartterT , PratterMR , et al. Optimal duration of corticosteroid therapy in the treatment of exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1998;157(3 Suppl):A801. ">Salam 1998</a>, <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a> and <a href="./references#CD006897-bbs2-0007" title="SirichanaW , SittipuntC , KawkitinarongK , WongtimS . Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology2008;13(Suppl 5):A120 [012‐01]. ">Sirichana 2008</a>; 14 days in <a href="./references#CD006897-bbs2-0002" title="GomaaM , FaramawyM , IbrahimH . Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]. European Respiratory Society 18th Annual Congress; 2008 Oct 3‐7; Berlin. 2008:[P3601]. ">Gomaa 2008</a>, <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>, <a href="./references#CD006897-bbs2-0004" title="Abdullah Al MamunSM , RahmanS . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Thorax2011;66(Suppl 4):A172. RahmanM , AbdullahA , MamunSM , HaqueMD . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Chest2004;126(4 Suppl):839S‐a. ">Rahman 2004</a> and <a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>; and 15 days in <a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a>. </p> <p>Three studies were published as full papers (<a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a>; <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>; <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a>), and additional data were supplied by the study author for <a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a>. Of five studies published only as abstracts in conference proceedings, data were supplied by authors for <a href="./references#CD006897-bbs2-0007" title="SirichanaW , SittipuntC , KawkitinarongK , WongtimS . Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology2008;13(Suppl 5):A120 [012‐01]. ">Sirichana 2008</a> and <a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>. Despite at least two requests, no data were made available for <a href="./references#CD006897-bbs2-0002" title="GomaaM , FaramawyM , IbrahimH . Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]. European Respiratory Society 18th Annual Congress; 2008 Oct 3‐7; Berlin. 2008:[P3601]. ">Gomaa 2008</a>, <a href="./references#CD006897-bbs2-0004" title="Abdullah Al MamunSM , RahmanS . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Thorax2011;66(Suppl 4):A172. RahmanM , AbdullahA , MamunSM , HaqueMD . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Chest2004;126(4 Suppl):839S‐a. ">Rahman 2004</a> and <a href="./references#CD006897-bbs2-0005" title="SalamT , AkersSM , LotanoR , ArnoldGK , BartterT , PratterMR , et al. Optimal duration of corticosteroid therapy in the treatment of exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1998;157(3 Suppl):A801. ">Salam 1998</a>. </p> </section> <section id="CD006897-sec-0062"> <h4 class="title">Excluded studies</h4> <p>A total of 23 studies with reasons for exclusion are listed in <a href="./references#CD006897-sec-0110" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD006897-sec-0063"> <h3 class="title">Risk of bias in included studies</h3> <p>The methodological quality of the published included trials was good; they were determined to have low risk of selection, performance, detection and attrition bias. Risk of bias was unclear in studies available only as abstracts (<a href="#CD006897-fig-0002">Figure 2</a> and <a href="#CD006897-fig-0003">Figure 3</a>). </p> <div class="figure" id="CD006897-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each item for each included study." data-id="CD006897-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each item for each included study. </p> </div> </div> </div> <div class="figure" id="CD006897-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006897-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD006897-sec-0064"> <h4 class="title">Allocation</h4> <p>In four studies (<a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a>; <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>; <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a>; <a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>) the randomisation procedure was adequate, but sequence generation was unclear. Allocation concealment was adequate in four studies (<a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a>; <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>; <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a>; <a href="./references#CD006897-bbs2-0007" title="SirichanaW , SittipuntC , KawkitinarongK , WongtimS . Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology2008;13(Suppl 5):A120 [012‐01]. ">Sirichana 2008</a>) but was not described in four studies. </p> </section> <section id="CD006897-sec-0065"> <h4 class="title">Blinding</h4> <p>Four studies were double blind (<a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a>; <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>; <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a>; <a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>). One study (<a href="./references#CD006897-bbs2-0007" title="SirichanaW , SittipuntC , KawkitinarongK , WongtimS . Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology2008;13(Suppl 5):A120 [012‐01]. ">Sirichana 2008</a>) was not blinded to participants or investigators. Blinding was unclear in the three other studies, although one study (<a href="./references#CD006897-bbs2-0002" title="GomaaM , FaramawyM , IbrahimH . Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]. European Respiratory Society 18th Annual Congress; 2008 Oct 3‐7; Berlin. 2008:[P3601]. ">Gomaa 2008</a>) stated that the study was single blinded but provided no further details. </p> </section> <section id="CD006897-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>Incomplete data were adequately addressed in four studies (<a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a>; <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>; <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a>; <a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>), but risk of bias was judged high in <a href="./references#CD006897-bbs2-0007" title="SirichanaW , SittipuntC , KawkitinarongK , WongtimS . Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology2008;13(Suppl 5):A120 [012‐01]. ">Sirichana 2008</a> and was unclear in three studies. </p> </section> <section id="CD006897-sec-0067"> <h4 class="title">Selective reporting</h4> <p>Three studies were assessed as free of selective reporting (<a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>; <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a>; <a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>), but risk of bias was unclear in five studies. </p> </section> </section> <section id="CD006897-sec-0068"> <h3 class="title" id="CD006897-sec-0068">Effects of interventions</h3> <p>See: <a href="./full#CD006897-tbl-0001"><b>Summary of findings for the main comparison</b> SCS treatment for 7 or fewer days compared with SCS treatment for longer than 7 days for acute exacerbations of COPD</a> </p> <section id="CD006897-sec-0069"> <h4 class="title">Primary outcomes</h4> <section id="CD006897-sec-0070"> <h5 class="title">1.1 Treatment failure</h5> <p>Four studies reported treatment failure that occurred during the index exacerbation, and the definition was provided in three studies (<a href="#CD006897-tbl-0002">Table 1</a>). No significant difference was noted in the likelihood of treatment failure between systemic corticosteroid for seven or fewer days and longer than seven days (n = 457; odds ratio (OR) 0.72, 95% confidence interval (CI) 0.36 to 1.46; <a href="./references#CD006897-fig-0006" title="">Analysis 1.1</a>; <a href="#CD006897-fig-0004">Figure 4</a>), and no statistical heterogeneity was observed. This result is equivalent to 22 fewer treatment failures per 1000 (95% CI 51 fewer to 34 more). The outcome was downgraded for imprecision and was rated as having moderate quality because the confidence intervals for the pooled effect included important benefit and potential harm. </p> <div class="figure" id="CD006897-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot outcome: treatment failure comparing systemic corticosteroids for ≤ 7 days vs &gt; 7 days." data-id="CD006897-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot outcome: treatment failure comparing systemic corticosteroids for ≤ 7 days vs &gt; 7 days. </p> </div> </div> </div> </section> <section id="CD006897-sec-0071"> <h5 class="title">1.2 Relapse</h5> <p>Relapse was measured as a new acute exacerbation or hospital admission for COPD in four studies: <a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a> (follow‐up period not stated), <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a> and <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a> (six‐month follow‐up) and <a href="./references#CD006897-bbs2-0007" title="SirichanaW , SittipuntC , KawkitinarongK , WongtimS . Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology2008;13(Suppl 5):A120 [012‐01]. ">Sirichana 2008</a> (30‐day follow‐up). No significant difference was reported between systemic corticosteroid use for seven or fewer days and for longer than seven days (n = 478; OR 1.04, 95% CI 0.7 to 1.56; <a href="./references#CD006897-fig-0007" title="">Analysis 1.2</a>; <a href="#CD006897-fig-0005">Figure 5</a>), and no statistical heterogeneity was observed. The outcome was downgraded for imprecision and was rated as having moderate quality because the confidence intervals for the pooled effect included important benefit and potential harm. </p> <div class="figure" id="CD006897-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Systemic corticosteroids for 7 or fewer days vs longer than seven days, outcome: 1.2 Relapse." data-id="CD006897-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Systemic corticosteroids for 7 or fewer days vs longer than seven days, outcome: 1.2 Relapse. </p> </div> </div> </div> </section> <section id="CD006897-sec-0072"> <h5 class="title">1.3 Time to re‐exacerbation</h5> <p>Time to next COPD exacerbation, defined as "acute‐onset worsening of the patient’s condition beyond day‐to‐day variations requiring interaction with a healthcare provider which could occur during the index exacerbation or during follow‐up," over six months of follow‐up was reported in one study (<a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>). This study adopted an a priori non‐inferiority definition, by which the proportion of participants with re‐exacerbation during follow‐up should be no more than 65% compared with 50% for standard treatment for an exacerbation, yielding a critical hazard ratio of 1.515. Time to the next exacerbation did not differ in this one large study, which was powered to detect non‐inferiority and compared five days versus 14 days of systemic corticosteroid treatment (n = 311; hazard ratio (HR) 0.95, 95% CI 0.66 to 1.37; <a href="./references#CD006897-fig-0008" title="">Analysis 1.3</a>). </p> </section> <section id="CD006897-sec-0073"> <h5 class="title">1.4 to 1.6 Adverse effects</h5> <p>1.4 Hyperglycaemia: In two studies (<a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>; <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a>) no difference was noted in the likelihood of hyperglycaemia between systemic corticosteroid for seven or fewer days and longer than seven days (n = 345; OR 0.99, 95% CI 0.64 to 1.53; <a href="./references#CD006897-fig-0009" title="">Analysis 1.4</a>), and no heterogeneity was observed. The outcome was downgraded for imprecision and was rated as having moderate quality because the confidence intervals for the pooled effect included important benefit and potential harm. </p> <p>1.5 Hypertension: In one trial (<a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>)no difference was noted in the likelihood of hypertension between systemic corticosteroid for seven or fewer days and longer than seven days (n = 311; OR 0.61, 95% CI 0.31 to 1.22; <a href="./references#CD006897-fig-0010" title="">Analysis 1.5</a>). </p> <p>1.6 Other adverse effects were reported in five studies and included gastrointestinal tract bleeding, symptomatic gastrointestinal reflux, symptoms of congestive heart failure or ischaemic heart disease, sleep disturbance, fractures and depression. No difference was noted in the likelihood of another adverse event between systemic corticosteroids for seven or fewer days and longer than seven days (n = 503; OR 0.89, 95% CI 0.46 to 1.69; <a href="./references#CD006897-fig-0011" title="">Analysis 1.6</a>). The outcome was downgraded for imprecision and was rated as having moderate quality because the confidence intervals for the pooled effect included important benefit and potential harm. </p> </section> </section> <section id="CD006897-sec-0074"> <h4 class="title">Secondary outcomes</h4> <section id="CD006897-sec-0075"> <h5 class="title">1.7 Mortality</h5> <p>In two studies the likelihood of mortality did not differ between systemic corticosteroid for seven or fewer days and longer than seven days (n = 336; OR 0.91, 95% CI 0.40 to 2.06; <a href="./references#CD006897-fig-0012" title="">Analysis 1.7</a>). The outcome was downgraded for imprecision and was rated as having moderate quality because the confidence intervals for the pooled effect included important benefit and potential harm. </p> </section> <section id="CD006897-sec-0076"> <h5 class="title">1.8 Length of hospitalisation</h5> <p>In three studies no difference was noted in length of hospital stay between systemic corticosteroid for seven or fewer days and longer than seven days (n = 421; mean difference (MD) ‐0.61 days, 95% CI ‐1.51 to 0.28; <a href="./references#CD006897-fig-0013" title="">Analysis 1.8</a>). The outcome was downgraded for imprecision and was rated as having moderate quality because the confidence intervals for the pooled effect included important benefit and potential harm. </p> </section> <section id="CD006897-sec-0077"> <h5 class="title">1.9 to 1.14 Lung function</h5> <p>In three studies no difference was noted in absolute FEV<sub>1</sub> measured within seven days between systemic corticosteroid for seven or fewer days and longer than seven days (n = 96; MD ‐0.07 litres, 95% CI ‐0.19 to 0.05; <a href="./references#CD006897-fig-0014" title="">Analysis 1.9</a>), and no heterogeneity was observed. <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a> reported lung function as FEV<sub>1</sub> percentage predicted and noted no difference between systemic corticosteroid for seven or fewer days and longer than seven days (n = 289; MD 0.76%, 95% CI ‐3.15 to 4.66; <a href="./references#CD006897-fig-0015" title="">Analysis 1.10</a>). In three studies no difference was noted in early response of FVC between systemic corticosteroid for seven or fewer days and longer than seven days (n = 97; MD 0.01 L, 95% CI ‐0.20 to 0.22; <a href="./references#CD006897-fig-0016" title="">Analysis 1.11</a>), and no statistical heterogeneity was observed. </p> <p>For lung function measured at the end of treatment in four studies, no difference was noted in FEV<sub>1</sub> between systemic corticosteroid for seven or fewer days and longer than seven days (n = 187; MD ‐0.04 litres, 95% CI ‐0.19 to 0.10; <a href="./references#CD006897-fig-0017" title="">Analysis 1.12</a>); important heterogeneity was observed (Chi² = 7.17, df = 3 (P value 0.07), I² = 58%). The outcome was rated as having very low quality and was downgraded for imprecision because the confidence intervals for the pooled effect included important benefit and potential harm, and risk of attrition bias and inconsistency were due to unexplained heterogeneity. In <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>, no difference was noted in FEV<sub>1</sub> percentage predicted at 30 days between systemic corticosteroid for seven or fewer days and more than seven days (n = 289; MD 1.29%, 95% CI ‐3.35 to 5.93; <a href="./references#CD006897-fig-0018" title="">Analysis 1.13</a>). In three studies no difference was noted in FVC at the end of treatment between systemic corticosteroid for seven or fewer days and longer than seven days (n = 99; MD ‐0.12, 95% CI ‐0.33 to 0.09; <a href="./references#CD006897-fig-0019" title="">Analysis 1.14</a>), and no heterogeneity was observed. </p> </section> <section id="CD006897-sec-0078"> <h5 class="title">1.15 to 1.17 Arterial blood gases</h5> <p><a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a> reported partial pressure of oxygen in arterial blood (PaO<sub>2</sub>) before seven days (n = 34). No difference was noted between treatment with systemic corticosteroid for seven or fewer days and longer than seven days (MD ‐0.20 mmHg; 95% CI ‐9.21 to 8.81; <a href="./references#CD006897-fig-0020" title="">Analysis 1.15</a>). </p> <p>In two studies (n = 121) at completion of treatment, no difference was noted in PaO<sub>2</sub> after 10 to 14 days of follow‐up between systemic corticosteroid for seven or fewer days and longer than seven days (MD ‐1.38 mmHg; 95% CI ‐4.96 to 2.21; <a href="./references#CD006897-fig-0021" title="">Analysis 1.16</a>). </p> <p>In <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a> (n = 34) no difference was noted in partial pressure of carbon dioxide in arterial blood (PaCO<sub>2</sub>) after three days (MD ‐1.80 mmHg, 95% CI ‐11.14 to 7.54) or after 10 days (MD 1.50 mmHg, 95% CI ‐5.20 to 8.20) between treatment with systemic corticosteroid for seven or fewer days and longer than seven days (<a href="./references#CD006897-fig-0022" title="">Analysis 1.17</a>). </p> </section> <section id="CD006897-sec-0079"> <h5 class="title">1.18 to 1.19 Symptom scores</h5> <p>In two studies no differences were noted in dyspnoea scores when measured before seven days between systemic corticosteroid for seven or fewer days and longer than seven days (n = 320; standardised mean difference (SMD) ‐0.08, 95% CI ‐0.29 to 0.14; <a href="./references#CD006897-fig-0023" title="">Analysis 1.18</a>), and no statistical heterogeneity was observed. When expressed on the Medical Research Council (MRC) scale (1 to 5), this would equate to 0.1 units better (95% CI 0.4 better to 0.2 worse). </p> <p>In four studies at the end of treatment, no difference was noted in dyspnoea scores between systemic corticosteroid for seven or fewer days and longer than seven days (n = 404; SMD 0.16, 95% CI ‐0.03 to 0.36; <a href="./references#CD006897-fig-0024" title="">Analysis 1.19</a>),and moderate heterogeneity was observed (Chi² = 5.89, df = 3 (P value 0.12), I² = 49%). When expressed on the MRC scale (1 to 5), this would equate to 0.2 units worse (95% CI 0.04 better to 0.45 worse). </p> </section> <section id="CD006897-sec-0080"> <h5 class="title">1.20 to 1.21 Quality of life</h5> <p>Health‐related quality of life was assessed in <a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a> by using the acute bronchitis health‐related quality‐of‐life interview, which measures changes in health‐related quality of life among patients treated for chronic lung disease; it consists of 22 items in four domains: activity‐related limitations (six items); effects of symptoms (eight items); fatigue (four items); and emotional functioning (four items). Each item is rated on a 7‐point scale, and a difference of 0·5 points is taken to be the smallest important difference (<a href="./references#CD006897-bbs2-0046" title="EvansAT , HusainS , DurairajL , SadowskiLS , Charles‐DamteM , WangY . Azithromycin for acute bronchitis: a randomised, double‐blind, controlled trial. Lancet2002;359(9318):1648‐54. ">Evans 2002</a>). No difference was reported in overall score between systemic corticosteroid for seven or fewer days and longer than seven days when measured before seven days (n = 290; MD 0.03, 95% CI ‐0.15 to 0.21; <a href="./references#CD006897-fig-0025" title="">Analysis 1.20</a>) or after 30 days (n = 263; MD 0.07, 95% CI ‐0.11 to 0.25; <a href="./references#CD006897-fig-0026" title="">Analysis 1.21</a>). </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD006897-sec-0081" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD006897-sec-0081"></div> <section id="CD006897-sec-0082"> <h3 class="title" id="CD006897-sec-0082">Summary of main results</h3> <section id="CD006897-sec-0083"> <h4 class="title">SCS treatment for seven or fewer days compared with SCS treatment for longer than seven days for acute exacerbations of COPD </h4> <p>Please see <a href="./full#CD006897-tbl-0001">summary of findings Table for the main comparison</a>. </p> <p>The likelihood of treatment failure did not differ between treatment with systemic corticosteroids for seven or fewer days and longer than seven days over 10 to 14 days of follow‐up in four studies, although wide confidence intervals around the estimate were reported (457 participants; odds ratio (OR) 0.72, 95% confidence interval (CI) 0.36 to 1.46). This difference equates to 22 fewer people experiencing treatment failure per 1000 (95% CI 51 fewer to 34 more) for short‐duration corticosteroid treatment. Similarly, no difference was noted for re‐exacerbation over 14 to 180 days of follow‐up in four studies (478 participants; OR 1.04, 95% CI 0.7 to 1.56); this equates to nine fewer people with re‐exacerbation per 1000 (95% CI 68 fewer to 100 more) for longer‐duration corticosteroid treatment. Time to the next COPD exacerbation did not differ in one large study, which was powered to detect non‐inferiority and compared five days versus 14 days of systemic corticosteroid treatment (n = 311; hazard ratio 0.95, 95% CI 0.66 to 1.37). </p> <p>The likelihood of adverse drug effects when systemic corticosteroids given for seven or fewer days were compared with systemic corticosteroids given for longer than seven days did not differ for hyperglycaemia in two studies with data of moderate quality (n = 345; OR 0.99, 95% CI 0.64 to 1.53), nor for a range of other drug effects in five studies with data of low quality (n = 503; OR 0.88, 95% CI 0.46 to 1.69). Mortality during follow‐up of between 14 days and 180 days did not differ in two studies (n = 336; OR 0.91, 95% CI 0.40 to 2.06) with data of moderate quality. </p> <p>No differences in length of hospitalisation were noted in three studies (n = 421; MD ‐0.61 days, 95% CI ‐1.51 to 0.28) with data of moderate quality, and no differences in lung function at the end of treatment were reported in four studies (n = 187; mean difference (MD) in forced expiratory volume in one second (FEV<sub>1</sub>) ‐0.04 L, 95% CI ‐0.19 to 0.10) with data of very low quality. No difference in health‐related quality of life was observed in one study with data of moderate quality. </p> </section> </section> <section id="CD006897-sec-0084"> <h3 class="title" id="CD006897-sec-0084">Overall completeness and applicability of evidence</h3> <p>Five of the eight included studies were not published as full articles. Meta‐analyses were limited by the need to omit three studies for which no data could be extracted from abstracts, or for which no data were supplied by study authors (<a href="./references#CD006897-bbs2-0002" title="GomaaM , FaramawyM , IbrahimH . Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]. European Respiratory Society 18th Annual Congress; 2008 Oct 3‐7; Berlin. 2008:[P3601]. ">Gomaa 2008</a>; <a href="./references#CD006897-bbs2-0004" title="Abdullah Al MamunSM , RahmanS . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Thorax2011;66(Suppl 4):A172. RahmanM , AbdullahA , MamunSM , HaqueMD . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Chest2004;126(4 Suppl):839S‐a. ">Rahman 2004</a>; <a href="./references#CD006897-bbs2-0005" title="SalamT , AkersSM , LotanoR , ArnoldGK , BartterT , PratterMR , et al. Optimal duration of corticosteroid therapy in the treatment of exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1998;157(3 Suppl):A801. ">Salam 1998</a>). The small number of trials meant that no subgroup analyses were performed. </p> <p>One study (<a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>) closed prematurely because of the difficulty of recruiting participants who met the inclusion criterion stating that participants should not have commenced oral steroid treatment before recruitment. This stipulation also caused low recruitment for the ongoing study (<a href="./references#CD006897-bbs2-0033" title="ReidD , SoltaniA , Wood‐BakerR , WaltersEH . Personal correspondence2010. ">Reid 2010</a>). In many countries this is likely to be a barrier to conducting inpatient studies comparing corticosteroid treatment of shorter duration versus conventional duration of up to 14 days, as guidelines and action plans recommend early initiation of therapy. </p> <p>As this review excluded studies in which participants received assisted ventilation (invasive or non‐invasive), the findings are not generalisable to people on assisted ventilation. Doses of systemic corticosteroid given to patients admitted to an intensive care unit (ICU) who may require assisted ventilation usually are much higher than those given in the studies included in this review (<a href="./references#CD006897-bbs2-0055" title="KiserTH , AllenRR , ValuckRJ , MossM , VandivierRW . Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine2014;189(9):1052‐64. ">Kiser 2014</a>). An observational study evaluating corticosteroid use in patients admitted to the ICU with an exacerbation of chronic obstructive pulmonary disease (COPD) concluded that fewer deaths and shorter stays in hospital occurred among people treated with systemic corticosteroid at doses equivalent to less than 240 mg per day of methylprednisolone. An observational study involving patients admitted to a non‐intensive care setting with an exacerbation of COPD who received systemic corticosteroids did not assess duration of treatment; this study found that low‐dose corticosteroids (20 to 80 mg/d prednisone equivalent) administered orally were not associated with worse outcomes than were seen with high‐dose intravenous therapy (120 to 800 mg/d prednisone equivalent) during the first two hospital days (<a href="./references#CD006897-bbs2-0059" title="LindenauerPK , PekowPS , LahtiMC , LeeY , BenjaminEM , RothbergMB . Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA2010;303(23):2359‐67. ">Lindenauer 2010</a>). </p> </section> <section id="CD006897-sec-0085"> <h3 class="title" id="CD006897-sec-0085">Quality of the evidence</h3> <p>Studies that contributed to the meta‐analysis were at low risk of selection bias, although one study was at high risk of performance and detection bias from lack of blinding. Some heterogeneity between studies was observed with regard to the inclusion criteria. Many studies did not provide details of their inclusion criteria, including their definition of an acute exacerbation of COPD. Only three studies specified the severity of COPD in participants based on their lung function reading (FEV<sub>1</sub>) upon admission. Thresholds to define severity included FEV<sub>1</sub> less than 50% predicted in <a href="./references#CD006897-bbs2-0002" title="GomaaM , FaramawyM , IbrahimH . Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]. European Respiratory Society 18th Annual Congress; 2008 Oct 3‐7; Berlin. 2008:[P3601]. ">Gomaa 2008</a> and <a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>, and less than 35% predicted in <a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a>. Variation in the systemic corticosteroid used in the included studies was reported: Five used oral prednisolone, one at high then tapering dose (<a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>), and two used intravenous corticosteroid. However, oral and intravenous corticosteroids have been shown to have equal efficacy and should not, therefore, contribute to any heterogeneity (<a href="./references#CD006897-bbs2-0078" title="Therapeutic GuidelinesLtd . Therapeutic Guidelines: Respiratory. Version 4. Melbourne: Therapeutic Guidelines Ltd, 2009. ">Therapeutic Guidelines 2009</a>). Sensitivity analyses according to risks of bias due to lack of blinding or route of corticosteroid administration had no significant effects on pooled results (<a href="#CD006897-tbl-0003">Table 2</a>). Duration of follow‐up varied between studies and was not stated in four studies. Follow‐up periods may have been too short to allow detection of potential differences in relapse, mortality and readmission. Lack of data for pooling limited the analysis of some outcomes that are important to patients, such as quality of life. </p> <div class="table" id="CD006897-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sensitivity analyses</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Excluding Sirichana (not blinded)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>All studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Relapse</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.01 (0.66 to 1.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04 (0.70 to 1.56)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> early</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.09 (‐0.22 to 0.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.07 (‐0.19 to 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> end</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.06 (‐0.23 to 0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.04 (‐0.19 to 0.10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC early</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.00 (‐0.25 to 0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01 (‐0.20 to 0.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC end</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.14 (‐0.38 to 0.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.12 (‐0.33 to 0.09)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse event—other</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.48 to 1.82)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89 (0.46 to 1.69)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Excluding Sayiner (IV SCS)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>All studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment failure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66 (0.32 to 1.37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72 (0.36 to 1.46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Relapse</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.02 (0.67 to 1.56)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04 (0.70 to 1.56)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse event—hyperglycaemia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.99 (0.63 to 1.54)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.99 (0.64 to 1.53)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse event—other</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89 (0.46 to 1.69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89 (0.46 to 1.69)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> early</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 (‐0.19 to 0.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.07 (‐0.19 to 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> end</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.03 (‐0.06 to 0.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.04 (‐0.19 to 0.10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC early</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 (‐0.18 to 0.42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01 (‐0.20 to 0.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC end</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.06 (‐0.34 to 0.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.12 (‐0.33 to 0.09)</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD006897-sec-0086"> <h3 class="title" id="CD006897-sec-0086">Potential biases in the review process</h3> <p>The review authors made every effort to identify all relevant published and unpublished studies by using additional methods to identify studies that might not have been found during the main electronic search (e.g. searching drug company databases and clinical trial registration sites, checking reference lists). We did not routinely contact individual trial authors for additional data unless outcomes were clearly selectively reported. All review authors adhered to the most recent best practice guidelines in terms of study selection, resolution of disagreements, data extraction and analysis to reduce bias and error. We included all data obtained from the included studies, even those from studies at higher risk of bias with regard to participant withdrawals, such as <a href="./references#CD006897-bbs2-0007" title="SirichanaW , SittipuntC , KawkitinarongK , WongtimS . Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology2008;13(Suppl 5):A120 [012‐01]. ">Sirichana 2008</a>, but we performed sensitivity analysis to check whether omitting the study changed the results. We obtained data for one study (<a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a>) from an author from this review team; however, data extraction and analysis were performed in the same way as for the other studies. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD006897-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="1 Study flow diagram." data-id="CD006897-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>1 Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each item for each included study." data-id="CD006897-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD006897-fig-0003" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot outcome: treatment failure comparing systemic corticosteroids for ≤ 7 days vs &gt; 7 days." data-id="CD006897-fig-0004" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot outcome: treatment failure comparing systemic corticosteroids for ≤ 7 days vs &gt; 7 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Systemic corticosteroids for 7 or fewer days vs longer than seven days, outcome: 1.2 Relapse." data-id="CD006897-fig-0005" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Systemic corticosteroids for 7 or fewer days vs longer than seven days, outcome: 1.2 Relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 1 Treatment failure." data-id="CD006897-fig-0006" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 1 Treatment failure. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-02.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 2 Relapse." data-id="CD006897-fig-0007" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 2 Relapse. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 3 Time to re‐exacerbation." data-id="CD006897-fig-0008" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 3 Time to re‐exacerbation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 4 Adverse effect—hyperglycaemia." data-id="CD006897-fig-0009" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 4 Adverse effect—hyperglycaemia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 5 Adverse effect—hypertension." data-id="CD006897-fig-0010" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 5 Adverse effect—hypertension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 6 Other adverse effects—gastrointestinal tract bleeding, symptomatic gastrointestinal reflux, symptoms of congestive heart failure or ischaemic heart disease, sleep disturbance, fractures, depression." data-id="CD006897-fig-0011" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 6 Other adverse effects—gastrointestinal tract bleeding, symptomatic gastrointestinal reflux, symptoms of congestive heart failure or ischaemic heart disease, sleep disturbance, fractures, depression. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 7 Mortality." data-id="CD006897-fig-0012" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 7 Mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 8 Length of hospitalisation." data-id="CD006897-fig-0013" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 8 Length of hospitalisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 9 FEV1 (L) (early)." data-id="CD006897-fig-0014" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 9 FEV<sub>1</sub> (L) (early). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 10 FEV1 % predicted (6 days)." data-id="CD006897-fig-0015" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 10 FEV<sub>1</sub> % predicted (6 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 11 FVC (L) (early)." data-id="CD006897-fig-0016" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 11 FVC (L) (early). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 12 FEV1 (L) end of treatment." data-id="CD006897-fig-0017" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 12 FEV<sub>1</sub> (L) end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 13 FEV1 % predicted 30 days." data-id="CD006897-fig-0018" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 13 FEV<sub>1</sub> % predicted 30 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 14 FVC (L) end of treatment." data-id="CD006897-fig-0019" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 14 FVC (L) end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 15 PaO2 (mmHg) (early)." data-id="CD006897-fig-0020" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 15 PaO<sub>2</sub> (mmHg) (early). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 16 PaO2 (mmHg) end of treatment." data-id="CD006897-fig-0021" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 16 PaO<sub>2</sub> (mmHg) end of treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 17 PaCO2 (mmHg)." data-id="CD006897-fig-0022" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 17 PaCO<sub>2</sub> (mmHg). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 18 Symptoms—dyspnoea (early)." data-id="CD006897-fig-0023" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 18 Symptoms—dyspnoea (early). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 19 Symptoms—dyspnoea (15 days)." data-id="CD006897-fig-0024" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 19 Symptoms—dyspnoea (15 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 20 Quality of life—overall (6 days)." data-id="CD006897-fig-0025" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 20 Quality of life—overall (6 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD006897-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/urn:x-wiley:14651858:media:CD006897:CD006897-CMP-001-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_t/tCD006897-CMP-001-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 21 Quality of life—overall (30 days)." data-id="CD006897-fig-0026" src="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Systemic corticosteroids for 7 or fewer days vs longer than 7 days, Outcome 21 Quality of life—overall (30 days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/media/CDSR/CD006897/image_n/nCD006897-CMP-001-21.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD006897-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">SCS treatment for 7 or fewer days compared with SCS treatment for longer than 7 days for acute exacerbations of COPD</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SCS treatment for 7 or fewer days compared with SCS treatment for longer than 7 days for acute exacerbations of COPD</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with acute exacerbations of COPD<br/> <b>Settings:</b> hospital‐initiated treatment<br/> <b>Intervention:</b> SCS treatment for 7 or fewer days<br/> <b>Comparison:</b> SCS treatment for longer than 7 days </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Number of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SCS treatment for longer than 7 days</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SCS treatment for 7 or fewer days</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Treatment failure</b><br/> Need for additional treatment<br/> Follow‐up: 10 to 14 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>83 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>61 per 1000</b><br/> (32 to 117) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.72</b> <br/> (0.36 to 1.46) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>457<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Equivalent to 22 fewer (95% CI 51 fewer to 34 more)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relapse</b><br/> New acute exacerbation or COPD‐related admission<br/> Follow‐up: 14 to 180 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>295 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>304 per 1000</b><br/> (227 to 395) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.04</b> <br/> (0.7 to 1.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>478<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>In one study (<a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a>), hazard ratio for time to re‐exacerbation was 0.95 (95% CI 0.66 to 1.37) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse drug effect</b> —<b>hyperglycaemia</b><br/> Follow‐up: 3 to 14 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>442 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>439 per 1000</b><br/> (336 to 548) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.99</b> <br/> (0.64 to 1.53) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>345<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse drug effects</b><br/> Gastrointestinal tract bleeding, symptomatic gastrointestinal reflux, symptoms of congestive heart failure or ischaemic heart disease, sleep disturbance, fractures, depression<br/> Follow‐up: 10 to 180 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>84 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>75 per 1000</b><br/> (40 to 135) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.88</b> <br/> (0.46 to 1.7) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>503<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>Low</b><sup>a,b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b><br/> Follow‐up: 14 to 180 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>77 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>71 per 1000</b><br/> (32 to 147) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.91</b> <br/> (0.4 to 2.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>336<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Length of hospitalisation</b><br/> (days)<br/> Follow‐up: 3 to 14 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean length of hospitalisation in control groups was<br/> <b>10 days</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean length of hospitalisation in intervention groups was<br/> <b>0.61 lower</b> (1.51 lower to 0.28 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>421<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lung function (end of treatment)</b><br/> FEV<sub>1</sub> (L)<br/> Follow‐up: 10 to 14 days </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean FEV<sub>1</sub> in control groups ranged from 0.84 to 1.14 L </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean lung function (end of treatment) in intervention groups was<br/> <b>0.04 lower</b> (0.19 lower to 0.10 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>187<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>Very low</b><sup>a,c,d,e</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Health‐related quality of life (QOL)</b> </p> <p>Overall score (includes activity limitations, symptoms, fatigue, emotional functioning); scale 0 best to 6 worst; minimum important difference 0.5 </p> <p>Follow‐up: 30 days</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean QOL score in control groups was 1.24</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean QOL score in intervention groups was <b>0.06 higher</b> (‐0.16 lower to 0.28 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>271 (1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>Moderate</b><sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence.<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Wide confidence intervals include significant benefit or harm (‐1 for imprecision).<br/> <sup>b</sup>Participants and physicians not blinded to treatment in one study (‐1 for risk of bias).<br/> <sup>c</sup>Participants and physicians not blinded to treatment in one study; however risk of bias for the outcome measurement is considered low.<br/> <sup>d</sup>High risk of attrition bias in one study (‐1 for risk of bias).<br/> <sup>e</sup>Significant unexplained heterogeneity (‐1 for inconsistency). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">SCS treatment for 7 or fewer days compared with SCS treatment for longer than 7 days for acute exacerbations of COPD</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006897-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study characteristics</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID/Setting</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Inclusion criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>AE definition</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N participants included/Completing</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean age, years</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>% males/ % smokers</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Prestudy SCS use, %</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SCS ≤ 7 days</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SCS &gt; 7 days</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Definition of treatment failure</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0001" title="ChenG , XieC . The efficacy and treatment length of oral corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease [Abstract]. European Respiratory Journal2005;26(Suppl 49):Abstract No. 1966. ChenG , XieCM , LuoYF . [The effects and therapeutic duration of oral corticosteroids in patients with acute exacerbation of chronic obstructive pulmonary diseases]. [Chinese]. Chinese Journal of Tuberculosis and Respiratory Diseases [Chung‐Hua Chieh Ho Ho Hu Hsi Tsa Chih]2008;31(8):577‐80. ">Chen 2005</a> China/ inpatients </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years of continuous productive cough, FEV<sub>1</sub>/FVC post BD &lt; 0.7, FEV<sub>1</sub> &lt; 80% predicted. No respiratory failure, diabetes or bronchial asthma </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At least 2 of 3 symptoms: increased sputum or dyspnoea or purulent sputum</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86/81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75/44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg/d 10 days + 15 mg/d 5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not known</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0002" title="GomaaM , FaramawyM , IbrahimH . Duration of systemic corticosteroids treatment in COPD exacerbations [Abstract]. European Respiratory Society 18th Annual Congress; 2008 Oct 3‐7; Berlin. 2008:[P3601]. ">Gomaa 2008</a> (abstract only) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub> &lt; 50% predicted, no respiratory acidosis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42/Not known</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 15 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0003" title='LeuppiJD , SchuetzP , BingisserR , BodmerM , BrielM , Drescher , et al. Short‐term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. JAMA2013;309(21):2223‐31. SchuetzP , LeuppiJD , BingisserR , BodmerM , BrielM , DrescherT , DuerringU , HenzenC , LeibbrandtY , MaierS , MiedingerD , MuellerB , ScherrA , SchindlerC , StoeckliR , ViatteS , vonGarnierC , TammM , RutishauserJ . Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the Reduction in the Use of Corticosteroids in Exacerbated COPD (REDUCE) trial. Eur J Endocrinol2015;173(1):19‐27. SchuetzP , LeuppiJD , TammM , BrielM , BingisserR , DürringU , et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease—the "REDUCE" trial. Swiss Medical Weekly2011;140(18 October 2010):w13109. '>Leuppi 2013</a> Switzerland/5 sites </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Age &gt; 40 years, smoking history ≥ 20 pack‐years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At least 2 of the following: change in baseline dyspnoea, cough or sputum quantity/purulence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>314/296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60/45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5 days: days 1 to 4 methylprednisolone 40 mg, days 2 to 5 oral prednisolone 40 mg</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14 days: days 1 to 4 methylprednisolone 40 mg, days 2 to 14 oral 40 mg prednisolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Received open‐label glucocorticoids during index exacerbation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0004" title="Abdullah Al MamunSM , RahmanS . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Thorax2011;66(Suppl 4):A172. RahmanM , AbdullahA , MamunSM , HaqueMD . Role of 7‐day and 14‐day courses of oral prednisolone treatment in acute exacerbation of COPD [Abstract]. Chest2004;126(4 Suppl):839S‐a. ">Rahman 2004</a> (abstract only) Bangladesh/1 site </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 14 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0005" title="SalamT , AkersSM , LotanoR , ArnoldGK , BartterT , PratterMR , et al. Optimal duration of corticosteroid therapy in the treatment of exacerbations of chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine1998;157(3 Suppl):A801. ">Salam 1998</a> (abstract only) USA/Unknown sites </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21/Not known</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None in previous month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IV CS 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IV CS 3 days + 7 days OCS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0006" title="SayinerA , AytemurZA , CiritM , UnsalI . Systemic glucocorticoids in severe exacerbations of COPD. Chest2001;119(3):726‐30. ">Sayiner 2001</a> Turkey/1 site </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>FEV<sub>1</sub> &lt; 35% predicted, PYH &gt; 20, no respiratory failure requiring ventilation </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated, requiring admission</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36/34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94/Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None in previous month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IV methylprednisone 0.5 mg/kg qds 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IV methylprednisone 0.5 mg/kg qds 3 days, bd 3 days, od 4 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required open‐label steroid treatment</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0007" title="SirichanaW , SittipuntC , KawkitinarongK , WongtimS . Comparison between 5 days and 10 days of prednisolone in treatment of acute exacerbation of chronic obstructive pulmonary disease [Abstract]. Respirology2008;13(Suppl 5):A120 [012‐01]. ">Sirichana 2008</a> (abstract and author data) Thailand/1 site </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Age &gt; 40 years, symptoms &gt; 24 hours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increase in at least 2 of 3 symptoms—dyspnoea, sputum volume, sputum purulence; requiring admission </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48/42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88/Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None in previous month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 30 mg 10 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Outcome not reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD006897-bbs2-0008" title="Wood‐BakerR , WilkinsonJ , PearceM , RyanG . A double‐blind, randomised, placebo‐controlled trial of corticosteroids for acute exacerbations of chronic obstructive pulmonary disease [Abstract]. Australian &amp; New Zealand Journal of Medicine1998;28:262. ">Wood‐Baker 1997</a> (abstract and author data) Australia &amp; New Zealand/2 sites </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Age &gt; 40 years; &gt; 10 pack‐year smoking history; FEV<sub>1</sub> &lt; 50% predicted </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not stated, requiring admission</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38/28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63/Not stated</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None for current AEs, no long‐term OS &gt; 5 mg/d</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 2.5 mg/kg orally daily for 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prednisolone 0.6 mg/kg orally daily for 7 days followed by prednisolone 0.3 mg/kg orally daily for 7 days </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lack of progress according to attending physician during treatment</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Study characteristics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD006897-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sensitivity analyses</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Excluding Sirichana (not blinded)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>All studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Relapse</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.01 (0.66 to 1.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04 (0.70 to 1.56)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> early</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.09 (‐0.22 to 0.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.07 (‐0.19 to 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> end</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.06 (‐0.23 to 0.11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.04 (‐0.19 to 0.10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC early</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.00 (‐0.25 to 0.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01 (‐0.20 to 0.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC end</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.14 (‐0.38 to 0.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.12 (‐0.33 to 0.09)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse event—other</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.48 to 1.82)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89 (0.46 to 1.69)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Excluding Sayiner (IV SCS)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>All studies</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment failure</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66 (0.32 to 1.37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72 (0.36 to 1.46)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Relapse</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.02 (0.67 to 1.56)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04 (0.70 to 1.56)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse event—hyperglycaemia</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.99 (0.63 to 1.54)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.99 (0.64 to 1.53)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse event—other</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89 (0.46 to 1.69)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89 (0.46 to 1.69)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> early</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.02 (‐0.19 to 0.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.07 (‐0.19 to 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FEV<sub>1</sub> end</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.03 (‐0.06 to 0.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.04 (‐0.19 to 0.10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC early</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 (‐0.18 to 0.42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01 (‐0.20 to 0.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>FVC end</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.06 (‐0.34 to 0.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.12 (‐0.33 to 0.09)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Sensitivity analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/full#CD006897-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD006897-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Systemic corticosteroids for 7 or fewer days vs longer than 7 days</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Treatment failure <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.36, 1.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Relapse <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>478</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.70, 1.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Time to re‐exacerbation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Hazard Ratio (Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse effect—hyperglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>345</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.64, 1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Adverse effect—hypertension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Other adverse effects—gastrointestinal tract bleeding, symptomatic gastrointestinal reflux, symptoms of congestive heart failure or ischaemic heart disease, sleep disturbance, fractures, depression <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.46, 1.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.40, 2.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Length of hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐1.51, 0.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 FEV<sub>1</sub> (L) (early) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.19, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 FEV1 absolute</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.22, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 FEV1 change</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.27, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 FEV<sub>1</sub> % predicted (6 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 FVC (L) (early) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.20, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 FVC measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.29, 0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 FVC change from baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [‐0.23, 0.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 FEV<sub>1</sub> (L) end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.19, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 FEV1 measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.25, 0.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 FEV1 change from baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.23, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 FEV<sub>1</sub> % predicted 30 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 FVC (L) end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.12 [‐0.33, 0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 FVC measured</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.14 [‐0.39, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 FVC change from baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.44, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 PaO<sub>2</sub> (mmHg) (early) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 PaO<sub>2</sub> (mmHg) end of treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.38 [‐4.96, 2.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 PaCO<sub>2</sub> (mmHg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 3 days of follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 10 days of follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Symptoms—dyspnoea (early) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.29, 0.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Symptoms—dyspnoea (15 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.03, 0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 Change</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.09, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 Absolute</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>271</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.12 [‐0.12, 0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Quality of life—overall (6 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Quality of life—overall (30 days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Systemic corticosteroids for 7 or fewer days vs longer than 7 days</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD006897.pub4/references#CD006897-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD006897.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD006897-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD006897-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD006897-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD006897-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD006897-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD006897-note-0009">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006897\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006897\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006897\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006897\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006897\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xNbeAU8n&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006897.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006897.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD006897.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD006897.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006897.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740716836455"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006897.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740716836459"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD006897.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918da93dbb1e1be3',t:'MTc0MDcxNjgzNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 